Your browser doesn't support javascript.
loading
Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
Ugurlu, Serdal; Ergezen, Bilgesu; Egeli, Bugra Han; Selvi, Oguzhan; Ozdogan, Huri.
Afiliação
  • Ugurlu S; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
  • Ergezen B; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
  • Egeli BH; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
  • Selvi O; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
  • Ozdogan H; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul-Cerrahpasa, Istanbul, Turkey.
Rheumatology (Oxford) ; 59(12): 3892-3899, 2020 Dec 01.
Article em En | MEDLINE | ID: mdl-32556219
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Familiar do Mediterrâneo / Interleucina-1 / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 / Anticorpos Monoclonais Humanizados / Amiloidose Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Familiar do Mediterrâneo / Interleucina-1 / Antirreumáticos / Proteína Antagonista do Receptor de Interleucina 1 / Anticorpos Monoclonais Humanizados / Amiloidose Idioma: En Ano de publicação: 2020 Tipo de documento: Article